Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease.
Large randomized clinical trials (RCT) supporting guidelines for the management of heart failure with reduced ejection fraction (HFrEF) have typically excluded patients with advanced chronic kidney disease (CKD). Patients with concomitant advanced CKD and HFrEF experience poor cardiovascular outcomes and mortality relative to either disease in isolation and have been shown to consistently receive lower rates of HFrEF guideline-directed medical therapy (GDMT). This review evaluated recent evidence for the use of GDMT in patients with HFrEF and advanced CKD approaching dialysis from RCTs and observational cohorts. The authors also discuss the limitations and challenges inherent in the evidence for GDMT in this population, and offer guidance to clinicians for proper clinical use and future research directions.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Stroke Volume
- Silicates
- Severity of Illness Index
- Risk Assessment
- Renal Insufficiency, Chronic
- Practice Guidelines as Topic
- Polymers
- Mineralocorticoid Receptor Antagonists
- Hyperkalemia
- Humans
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Stroke Volume
- Silicates
- Severity of Illness Index
- Risk Assessment
- Renal Insufficiency, Chronic
- Practice Guidelines as Topic
- Polymers
- Mineralocorticoid Receptor Antagonists
- Hyperkalemia
- Humans